144
Participants
Start Date
Not specified
Study Completion Date
May 31, 2008
HIV-1 gag DNA
A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid
HIV-1 gag DNA plus IL-12 DNA adjuvant
Injection IL-12 DNA adjuvant intramuscularly into the deltoid
CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine)
A 1 mL intramuscular injection in the deltoid
Sodium chloride injection (0.9%)
"All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273."
Project Brave HIV Vaccine CRS, Baltimore
Vanderbilt Vaccine CRS, Nashville
Alabama Vaccine CRS, Birmingham
Chiang Mai Univ. HVTN CRS, Chiang Mai
National Institute of Allergy and Infectious Diseases (NIAID)
NIH